Salvage Therapy With Selpercatinib for RET-Rearranged NSCLC With Pralsetinib-Related Pneumonitis and Leptomeningeal Disease: A Case Report

Selpercatinib and pralsetinib are RET inhibitors with substantial activity in advanced RET-rearranged NSCLC. We present a case of pralsetinib-related pneumonitis and leptomeningeal and brain metastases progression during treatment suspension for pneumonitis. During recovery, selpercatinib administra...

Descripción completa

Detalles Bibliográficos
Autores principales: d'Arienzo, Paolo D., Cunningham, Niamh, O’Sullivan, Hazel, Grieco, Charlotte, Patel, Virjen, Popat, Sanjay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10687334/
https://www.ncbi.nlm.nih.gov/pubmed/38034820
http://dx.doi.org/10.1016/j.jtocrr.2023.100581

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10687334/
https://www.ncbi.nlm.nih.gov/pubmed/38034820
http://dx.doi.org/10.1016/j.jtocrr.2023.100581

Ejemplares similares